📰 Randomized Phase News
Page 10 - Randomized Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Phase. Real-time updates on events, politics, business and more.
May 20, 2022
Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients PFS rate at 12 months with...
May 12, 2022
Data from four pivotal trials continue to build evidence base for BRUKINSA (zanubrutinib) in B-cell malignancies Pipeline showing promise with early data for BGB-11417, a BCL-2 inhibitor, as monotherapy
May 10, 2022
In a third interim analysis for the randomized Phase 2 ARC-7 study, both anti-TIGIT domvanalimab-containing arms continued to show meaningful differentiation compared to the anti-PD1 antibody zimberelimab alone when given as a treatment for first-line metastatic non-small cell lung cancer (NSCLC); we expect to provi...
May 10, 2022
10.05.2022 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that data for six approved medicines and pipeline candidates in more than 25 types of cancer will be presented at the 2022 American Society of Clinical Oncology ...
May 10, 2022
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the quarter ended March 31, 2022. Over the first quarter of 2022, all of Transgene’s preclinical and clinical assets progressed in line with ...
March 22, 2022
/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest...
December 21, 2021
HEIDELBERG, Germany and CAMBRIDGE, Mass, Dec. 21, 2021 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol
December 11, 2021
/PRNewswire/ -- Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition point to the transformative...
December 11, 2021
/PRNewswire/ -- Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition point to the transformative...
December 6, 2021
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from its hematology pipeline and marketed portfolio to be presented at the 63rd American Society...